Ocular Therapeutix, Inc. is a biopharmaceutical company committed to redefining the retina experience across development, treatment, and outcomes. OTX-TKI (also known as AXPAXLI™), Ocular’s investigational product candidate for retinal disease, is an axitinib intravitreal hydrogel based on its ELUTYX™ proprietary bioresorbable hydrogel-based technology. It is currently in Phase 3 clinical trials to advance wet age-related macular degeneration (AMD) and diabetic retinopathy (DR) treatment, aiming to improve long-term outcomes while reducing the frequency of injections. | Ocular Therapeutix, Inc. is a biopharmaceutical company committed to improving vision in the real world through the development and commercialization of innovative therapies for retinal diseases and other eye conditions.
New World Medical
At New World Medical, our mission is to preserve and enhance vision by delivering innovations to Benefit Humanity. Our innovations include the Ahmed® Family of Glaucoma Drainage Devices, the KDB GLIDE® and the STREAMLINE® Surgical System. NEW WORLD MEDICAL ~ HUMANITY’S VISION IS OUR FOCUS. www.newworldmedical.com
EXCEL OPTICS (P) LIMITED
Manufacture IOL’s in various models including Private Labels. GMP Certified Facility with ISO 13485 and CE. Millions of our IOL’s have been implanted worldwide. We have PMMA Rigid IOL’s, Hydrophilic and Hydrophobic Foldable IOL’s . All models are available in Mono Focal and Multi Focal. IRIS CLAW,CornealRing,CTR&Segments